Streamlining dossier preparation How medical writers drive success Read the whitepaper The methods and technologies advancing Alzheimer’s and Parkinson’s R&D Read the whitepaper Early phase challenges for biotechs Read the whitepaper Exploring FDA guidance for modern Data Monitoring Committees What you need to know for compliant, efficient safety and efficacy monitoring Read the whitepaper Streamlining dossier preparationThe methods and technologies advancing Alzheimer’s and Parkinson’s R&DEarly phase challenges for biotechsExploring FDA guidance for modern Data Monitoring Committees A multifaceted risk factor: Addressing obesity's impact across the disease spectrum Considerations for clinical trial design focused on obesity treatments. Digital Disruption Surveying the industry's evolving landscape. De-risking clinical development of precision medicines in oncology An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches. Clinical strategies to optimise SaMD for treating mental health The rise of mental health awareness, coupled with rapid technological advancements, is transforming mental health treatment. Featured Solutions Previous Blended solutions Bespoke, seamless solutions to meet unique sponsor challenges. Outcome Measures A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients. Biotech ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation. Cardiac Safety Solutions End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies. Early Clinical and Bioanalytical Solutions Innovative early clinical solutions that will advance your drug development strategy. Site & Patient Solutions Transforming recruitment through patient-centric trials and real-world, real-time data. Market Access Expertise in mission-critical pricing, market access, and reimbursement. Specialty Laboratory Solutions Supporting precision medicine programs across all phases of drug diagnostic co-development. Next123 Videos ICON overview ICON is expanding the possibilities of clinical research for customers, partners, and patients. Discover more Dismiss Video Modal Biotech Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach. Discover more Dismiss Video Modal Technology solutions ICON’s technology solutions are focused on the factors most critical to our customers. Discover more Dismiss Video Modal AI @ICON ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world. Discover more Dismiss Video Modal Webinars Strategies for ADC bioanalysis: Bioanalytical methods for antibody-drug conjugates (ADCs). 19 March 2025. Register today. Implementing digital health technologies for patient-centred trials 25 March 2025. Register now. Pregnant participants in clinical trials Watch the recording 1 ICON Insights Previous 10 Mar 2025 Navigating Pediatric Drug Development (PDP) in Canada: A comprehensive guide part 1 Read more 07 Mar 2025 Reassessing the UK's regulatory landscape post-Brexit Read more 04 Mar 2025 Endometriosis: A research and development call to action Read more 13 Feb 2025 Subtler scopes: Where IRA drug negotiations meet Part D redesigns Read more 13 Feb 2025 ICH GCP E6 (R3): Transformative updates make Good Clinical Practice better Read more 12 Feb 2025 An integrated approach for deeper insight with both open and closed claims data Read more 11 Feb 2025 Why translating core dossiers for marketing applications requires more than language skills Read more 11 Feb 2025 The future of medical science depends on transparency: Why plain language summaries matter Read more Next123 What’s happening in ICON